(Q44954105)

English

Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin

scientific article published in December 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin (English)

1 reference

Europe PubMed Central

7 December 2017

author name string

Lamparelli T

1

1 reference

Europe PubMed Central

7 December 2017

van Lint MT

2

1 reference

Europe PubMed Central

7 December 2017

Gualandi F

3

1 reference

Europe PubMed Central

7 December 2017

Raiola AM

4

1 reference

Europe PubMed Central

7 December 2017

Barbanti M

5

1 reference

Europe PubMed Central

7 December 2017

Sacchi N

6

1 reference

Europe PubMed Central

7 December 2017

Ficai G

7

1 reference

Europe PubMed Central

7 December 2017

Ghinatti C

8

1 reference

Europe PubMed Central

7 December 2017

Bregante S

9

1 reference

Europe PubMed Central

7 December 2017

Berisso G

10

1 reference

Europe PubMed Central

7 December 2017

Dominietto A

11

1 reference

Europe PubMed Central

7 December 2017

Di Grazia C

12

1 reference

Europe PubMed Central

7 December 2017

Bruno B

13

1 reference

Europe PubMed Central

7 December 2017

Sessarego M

14

1 reference

Europe PubMed Central

7 December 2017

Casarino L

15

1 reference

Europe PubMed Central

7 December 2017

Verdiani S

16

1 reference

Europe PubMed Central

7 December 2017

Bacigalupo A

17

1 reference

Europe PubMed Central

7 December 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

7 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

7 December 2017

26

1 reference

Europe PubMed Central

7 December 2017

12

1 reference

Europe PubMed Central

7 December 2017

1305-1311

1 reference

Europe PubMed Central

7 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702719

0 references

Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

21 January 2018

Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702719

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702719

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44954105&oldid=2059452548"